One of these mechanisms may be a reduction of some neurotransmitters (e.g. nitric oxide, noradrenalin, and substance P) in nerve terminals of patients with diabetic neuropathy that this may be associated to migraine pathophysiology [20]. This evidence concerns the gene TAC1 and migraine disorder.